INTERNATIONAL PATENT: CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL, NEXPLASMAGEN INC. FILES APPLICATION FOR "PLASMA-BASED TREATMENT OF CANCER"

GENEVA, Dec. 21 -- CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (850 rue Saint-DenisPavillon SMontreal, Quebec H2X 0A9), NEXPLASMAGEN INC. (3801 avenue WilsonMontreal, Quebec H4A 2T7) filed a patent application (PCT/CA2025/050792) for "PLASMA-BASED TREATMENT OF CANCER" on Jun 09, 2025. With publication no. WO/2025/255650, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WONG, Philip (12 Douglas AvenueToronto, Ontario M5M 1G5), LAFONTAINE, Julie (2255 rue SheppardMontreal, Quebec H2K 3L1), GLORY, Audrey (6345 avenue Henri...